Lina Ha, MD | |
Msc11 6025, 1 University Of New Mexico, Albuquerque, NM 81731 | |
(505) 272-5062 | |
(505) 272-6503 |
Full Name | Lina Ha |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | Msc11 6025, Albuquerque, New Mexico |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417416447 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 125073540 (Illinois) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lina Ha, MD Msc11 6025, 1 University Of New Mexico, Albuquerque, NM 81731 Ph: (505) 272-5062 | Lina Ha, MD Msc11 6025, 1 University Of New Mexico, Albuquerque, NM 81731 Ph: (505) 272-5062 |
News Archive
Groundbreaking research led by a team of scientists including a University of Massachusetts Amherst biostatistician shows that oral hormone therapy (HT) significantly alters the metabolome of postmenopausal women.
Pathway Genomics Inc., a U.S. based genetic testing company, announced the immediate availability of its personal Genetic Health Report. This customized and innovative personal genetic health report contains information on more than 70 health conditions, including pharmacogenetics (prescription medication response), propensity for complex disease, and carrier status (pre-pregnancy health).
Congenital cytomegalovirus (CMV) infection can cause serious complications such as hearing difficulties and mental retardation in affected infants.
Though autism is often not diagnosed until the age of three, some children begin to show signs of developmental delay before they turn a year old. While not all infants and toddlers with delays will develop autism spectrum disorders (ASD), experts point to early detection of these signs as key to capitalizing on early diagnosis and intervention, which is believed to improve developmental outcomes.
Pregnant women are at high risk for severe COVID-19 infection and death. Yet, insufficient safety data on babies has led many guidelines to leave the decision-making and potential threats to future mothers. While the vaccine trials did not directly test pregnant women, more real-world data suggests the vaccine may provide immunity benefits to newborns through breastmilk.
› Verified 1 days ago